MDxHealth S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MDxHealth S.A. with three other
miscellaneous service companies in Europe:
Bioventix Plc
of UNITED KINGDOM
(2019
sales of £9.29 million [US$12.34 million]
),
Evolva Holding SA
of SWITZERLAND
(11.60 million Swiss Francs [US$12.71 million]
of which 100%
was Novel Food Nutritional & Pharmaceutical), and
MediGene AG
which is
based in GERMANY
(10.63 million Euros [US$12.63 million]
of which 92%
was Immunotherapies).
Sales Analysis.
MDxHealth S.A. reported sales of 10.54 million Euro (US$12.52 million)
for the
year ending
December of 2019.
This
represents
a
sharp
decrease of 56.3%
versus 2018, when the company's sales were 24.10 million Euro.